Q2 Solutions Q2 Solutions Actionable Insights for Better Health and Lab Solutions
Refine Results

Diabetes is fast becoming a global healthcare epidemic. The number of people with diabetes rose from 108 million in 1980 to 422 million in 2014, with related deaths projected to rise by more than 50 percent in the next 10 years (http://www.who.int/mediacentre/factsheets/fs312/en/).  Lack of awareness and access to proper treatment can also lead to serious complications, such as blindness, amputation and kidney failure. And while the healthcare industry is effective at managing diabetes as a disease, physicians and patients could be doing more to test for early warning signs that indicate that these complications are emerging.  The need for early diagnosis and better monitoring is the... Read More

Today’s complex clinical trials need the support of a laboratory that can provide scientific, technological, and operational expertise to better meet the needs of patients, sites, and the sponsors they support. Costa Panagos, CEO Q2 Solutions Today’s drug development pipeline includes many new and exciting opportunities – from precision medicine approaches to complex targeted therapies, compounds and drug-specific companion diagnostics.  To improve the probability of success for this pipeline, collaborative teams with a wide range of expertise are required. The days when a single biopharmaceutical company might develop an oncology drug from preclinical research through market delivery are... Read More

The 2014 Ebola crisis unfolded like a Hollywood movie, with gruesome deaths, tragic stories, and global panic about its potential spread. Ebola had never spread so far or fast in the known history of the disease. Prior outbreaks were limited to a handful of cases in isolated communities that, while frightening, were easy to contain. But this was different. The outbreak, which stretched from March 2014 to October 2015, with ongoing sporadic cases continuing to occur in Guinea, spread across three countries in Africa, infecting more than 28,000 people and leaving more than 11,300 people dead. It’s a tragic story but it has real consequences in the world of vaccine development. As we... Read More

Topics

Vaccines